$38.00 -3.79 (-9.069%) Sarepta Therapeutics Inc - NASDAQ

Oct. 6, 2015 | 04:00 PM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
2/27/2015Christopher Nishan GarabedianPresident and CEO800$11.822.78%
2/27/2015Kaye Edward M. MDSVP & Chief Medical Officer800$11.82156.56%
8/12/2014CHASE ANTHONY RDirector23,450$10.6854.86%
11/14/2013CHASE ANTHONY RDirector10,000$13.9531.50%
11/12/2013Aphale JayantSVP Technical Operations-15,933$12.56-65.21%
9/16/2013BEHRENS M KATHLEENDirector6,500$37.0417.26%
9/03/2013HODGMAN JOHNDirector-5,556$34.97-56.18%
9/03/2013HODGMAN JOHNDirector5,556$17.52128.23%
8/22/2013CHASE ANTHONY RDirector3,500$32.6812.39%
8/19/2013Price Ben GilDirector500$31.181.44%
6/14/2013CHASE ANTHONY RDirector10,000$38.5054.81%
11/28/2012CHASE ANTHONY RDirector-1,600$28.17-6.12%
11/28/2012CHASE ANTHONY RDirector-5,700$29.70-23.22%
11/28/2012CHASE ANTHONY RDirector-1,600$30.21-8.49%
11/27/2012CHASE ANTHONY RDirector-1,100$29.04-4.04%
11/14/2012CHASE ANTHONY RDirector-800$26.26-2.85%
11/14/2012CHASE ANTHONY RDirector-9,200$25.65-24.70%
9/07/2012CHASE ANTHONY RDirector-13,300$13.95-18.93%
9/07/2012CHASE ANTHONY RDirector-19,700$14.79-34.60%
9/07/2012BEHRENS M KATHLEENDirector9,700$14.5850.61%
9/07/2012BEHRENS M KATHLEENDirector7,800$14.9127.02%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (SRPT), click here.
Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!